Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

Zacks #1 Stocks on the Move 05/21/2013

Company Name Symbol %Change
SCIENTIFIC L SCIL
8.00%
NATUS MEDICA BABY
6.11%
SUMMER INFAN SUMR
6.02%
RADIANT LOGI RLGT
5.32%
NEW ORIENTAL EDU
4.51%
Zacks ZACKS.COM
PROFIT from the PROS

Tactics that Work in Good Markets and Bad
 
--

Dear Subscriber,

Although some details about the stress test were released on Friday, the actual results have yet to be rendered. Though the continued uncertainty did not move the markets much, it certainly added to the overall stress felt by investors.

Steve Reitmeister, Kevin Matras and I discuss what the stress test and the recent market's action means for your portfolio in the Roundtable Review.

Also, the swine flu dominated the headlines yesterday and spurred buying activity of some drug company stocks. Jason Napodano discusses why the outbreak will not have any near-term impact on drug company earnings in our Analyst Blog.

Wishing you prosperity,
Charles Rotblut, CFA
Senior Market Analyst & Editor,
Profit From the Pros

 

 

Today's Top Stories: Tuesday- April 28, 2009

ZACKS RANK BUY STOCKS

  • Aggressive Growth - Marten Trasport, Ltd. (MRTN) reported first-quarter results which included a 53% jump in net income, which is now $4.1 million, up from $2.7 million. Earnings per share were 18 cents, compared to the 14 cents that analysts were expecting. Read More...
     
  • Growth & Income - DeVry, Inc. (DV) saw a nice spike in share price after delivering strong results for the fiscal third quarter. Earnings per share of 70 cents came in well ahead of last year’s 53 cents and topped the consensus estimate by 4.5%. Read More...
     
  • Momentum - Amazon.com, Inc. (AMZN) revenue was up 18% from last year to $4.89 billion. Income came in at $177 million, up 24% from last year, producing earnings of 41 cents per share, handily beating the consensus of 31 cents. Read More...
     
  • Value - NewMarket Corporation (NEU) is a Zacks #1 Rank (strong buy) stock. It has a forward P/E of 11.11. NEU's price-to-book is 2.69. The company also has an outstanding 5-year average return on equity (ROE) of 17.86%. Read More...
     

Learn how to profit from our exclusive Zacks Rank stock-ranking system with free resources. Read More...


Sponsor

JUST RELEASED: 3 Zacks Timely Reports To Help You Profit in 2009>>

Zacks Investment Management is offering 3 FREE Timely Reports to investors. Find out:

  • How to benefit from current market conditions
  • Where our analysts predict the economy is headed
  • The secrets behind our investing philosophy
  • Click Here Now.


    ZACKS MUTUAL FUND RANK
    • Best of Funds: Top Global Equity Funds
      First Eagle Global A (SGENX), ING Global Value Choice A (NAWGX) and Mutual Discovery A (TEDIX) are among the top-performing global equity mutual funds. Read More...

    The new Zacks Mutual Fund Rank is free until June 1. See all the great mutual fund resources.

    BEST OF ZACKS EQUITY RESEARCH

     


    PERSONAL FINANCE: provided by Kiplinger.com

    EDUCATION: Value

    How to Consider Insider Ownership Read More...

    PeopleAndPicks.com:

    VIP "Eversar" is finding opportunities in the market constellation with BUYS calls in (ABC), (CEPH), (FMC) and (NI). Read More...

     

    NEW ZACKS VIDEOS:

    EARNINGS TRENDS: Positive Surprises Lead to Fewer Estimate Cuts

    The ratio of estimate increases to cuts has climbed significantly over the last month. Highlighted stocks include: (CAT), (FCX), (IR), (PH) and (TXN). Read More...

    FACEBOOK

    Visit the Zacks.com Facebook page and get the latest insight on stocks and the market:
    Zacks On Facebook

    TWITTER

    Get the Zacks.com newsfeed delivered straight to your Twitter account:
    Zacks On Twitter

     

    OTHER ZACKS RESOURCES:

     

    Manage your Profit from the Pros subscription:

    REFER-A-FRIEND

    If you enjoy this e-mail newsletter, then please pass it along to a friend. Simply forward them the link below to sign up for their own free subscription. THANKS!
    Refer a Friend

    Regards and Happy Investing,

    Charles Rotblut, CFA
    Senior Market Analyst
    Zacks.com

    p.s. What is the mission for Zacks Profit from the Pros? To find out how we will help you become a more successful investor, click here.

    Visit /performance for information about the performance numbers displayed in this newsletter.

    Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

    To contact us by mail:

    Zacks Investment Research
    Attn: Profit from the Pros
    111 N. Canal St., Suite 1101
    Chicago, IL 60606

    To unsubscribe from receiving "Zacks.com Profit from the Pros"
    e-mail newsletter, Click here....

    Zacks Research is Reported On:

    Zacks Investment Research

    is an A+ Rated BBB

    Accredited Business.